Binnacle Investments Inc Neurocrine Biosciences Inc Transaction History
Binnacle Investments Inc
- $137 Billion
- Q1 2025
A detailed history of Binnacle Investments Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Binnacle Investments Inc holds 80 shares of NBIX stock, worth $9,634. This represents 0.01% of its overall portfolio holdings.
Number of Shares
80Holding current value
$9,634% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
645Shares Held
96.3MCall Options Held
312KPut Options Held
311K-
Black Rock Inc. New York, NY14.2MShares$1.71 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.2 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$667 Million0.37% of portfolio
-
State Street Corp Boston, MA4.89MShares$589 Million0.03% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$322 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.5B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...